title: Ploidy level determination and quantitative chromatin pattern description in pregnancy-associated breast cancers.
abstract: The present study deals with the characterization of hormone-sensitivity in pregnancy-associated breast cancers (PBCs). This characterization was carried out in 22 PBCs as opposed to 88 non-pregnancy-associated breast cancers (NPBCs). For this study, we used the digital cell image analysis of Feulgen-stained nuclei to assess the type of hormone-sensitivity. In a previous study it was demonstrated that the chromatin pattern in breast cancers is related to the amounts of estrogen receptors they contain. Our results demonstrated that the quantitative description of the chromatin pattern by means of 15 parameters (relating to morphometric, densitometric, and textural features) made it possible to identify typical cell nuclei populations in the PBC and NPBC groups. The use of specific statistical analyses (principal-components and discriminant) made it possible to quantify the proportion of each cell nucleus type in the PBCs. Furthermore, of the 22 PBCs under study, 13 contained a large majority of cell nuclei whose chromatin pattern was characteristic of hormone-sensitive cells, while 5 cases contained a large majority of typically hormone-insensitive ones. The remaining 4 cases contained a relatively similar proportion of typically hormone-sensitive and insensitive cell nuclei. The quantitative chromatin pattern description thus made it possible to characterize the hormone-sensitivity level in PBCs, whereas DNA ploidy level determination did not enable any such characterization to be carried out. The chromatin pattern assay described here, which enables hormone-sensitive pregnancy-associated breast cancers to be identified from hormone-insensitive ones independently from biochemical assays, should help the physician regarding therapy adaptation.
authors.affiliation: Department of Gyneco-Obstetrics, Federal University of Parana, Curitiba, Brasil.
authors.forename: V
authors.initials: V
authors.lastname: Budel
authors.forename: P
authors.initials: P
authors.lastname: Gasperin
authors.forename: S
authors.initials: S
authors.lastname: Hatschbach
authors.forename: T C
authors.initials: TC
authors.lastname: Cavalcanti
authors.forename: M
authors.initials: M
authors.lastname: Pétein
authors.forename: C
authors.initials: C
authors.lastname: Decaestecker
authors.forename: F
authors.initials: F
authors.lastname: Darro
authors.forename: I
authors.initials: I
authors.lastname: Salmon
authors.forename: R
authors.initials: R
authors.lastname: Kiss
mesh_terms: D001943:Breast Neoplasms / Q000737:chemistry / Q000235:genetics* / Q000648:ultrastructure; D002467:Cell Nucleus / Q000473:pathology; D002843:Chromatin; D004273:DNA, Neoplasm / Q000032:analysis*; D005260:Female; D006801:Humans; D019044:Image Cytometry / Q000379:methods; D015999:Multivariate Analysis; D009376:Neoplasms, Hormone-Dependent / Q000737:chemistry / Q000235:genetics* / Q000648:ultrastructure; D011003:Ploidies; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic; D011960:Receptors, Estrogen / Q000032:analysis
chemical_list: D002843:Chromatin; D004273:DNA, Neoplasm; D011960:Receptors, Estrogen